Takeda Pharmaceutical Co Ltd
TAK14.985USD
-0.095-0.63%
終値 06/25, 16:00（ET）15分遅れの株価
23.58B時価総額
0.11直近12ヶ月PER
詳細情報 Takeda Pharmaceutical Co Ltd 企業名
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, sale and licensing of pharmaceuticals. The Company focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The Company focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The Company operates in Japan, the United States, Europe, and China.
企業情報
企業コードTAK
会社名Takeda Pharmaceutical Co Ltd
上場日May 16, 1949
設立日1925
最高経営責任者「CEO」Mr. Christophe Weber
従業員数- -
証券種類Depository Receipt
決算期末May 16
本社所在地4F
都市CHUO-KU
証券取引所NYSE Consolidated
国Japan
郵便番号103-8668
電話番号81332782111
ウェブサイトhttps://www.takeda.com/
企業コードTAK
上場日May 16, 1949
設立日1925
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Steven H. (Steve) Gillis, Ph.D.
Dr. Steven H. (Steve) Gillis, Ph.D.
Independent Director
Independent Director
8.26K
--
Ms. Kimberly A. Reed
Ms. Kimberly A. Reed
Independent Director
Independent Director
1.38K
-85.30%
Mr. Christophe Weber
Mr. Christophe Weber
President, Chief Executive Officer, Representative Director
President, Chief Executive Officer, Representative Director
--
--
Ms. Emiko Higashi
Ms. Emiko Higashi
Independent Director
Independent Director
--
--
Dr. John M. Maraganore, Ph.D.
Dr. John M. Maraganore, Ph.D.
Independent Director
Independent Director
--
--
Ms. Miki Tsusaka
Ms. Miki Tsusaka
Independent Director
Independent Director
--
--
Mr. Koji Hatsukawa
Mr. Koji Hatsukawa
Independent Director
Independent Director
--
--
Mr. Milano Furuta
Mr. Milano Furuta
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Masami Iijima
Mr. Masami Iijima
Chairman of Board of Directors, Independent Director
Chairman of Board of Directors, Independent Director
--
--
Dr. Andrew S. Plump, Ph.D.
Dr. Andrew S. Plump, Ph.D.
President of Research & Development, Director
President of Research & Development, Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Steven H. (Steve) Gillis, Ph.D.
Dr. Steven H. (Steve) Gillis, Ph.D.
Independent Director
Independent Director
8.26K
--
Ms. Kimberly A. Reed
Ms. Kimberly A. Reed
Independent Director
Independent Director
1.38K
-85.30%
Mr. Christophe Weber
Mr. Christophe Weber
President, Chief Executive Officer, Representative Director
President, Chief Executive Officer, Representative Director
--
--
Ms. Emiko Higashi
Ms. Emiko Higashi
Independent Director
Independent Director
--
--
Dr. John M. Maraganore, Ph.D.
Dr. John M. Maraganore, Ph.D.
Independent Director
Independent Director
--
--
Ms. Miki Tsusaka
Ms. Miki Tsusaka
Independent Director
Independent Director
--
--
収益内訳
通貨: JPY更新時刻: Sun, Apr 6
通貨: JPY更新時刻: Sun, Apr 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
事業別JPY
会社名
収益
比率
Gastrointestinal diseases
344.12B
30.08%
Plasma derivatives
248.54B
21.72%
Rare diseases
190.32B
16.63%
Oncology
143.10B
12.51%
Neuroscience
141.94B
12.41%
Other
76.15B
6.66%
地域別JPY
会社名
収益
比率
United States
593.84B
51.90%
Europe And Canada (Country)
262.60B
22.95%
Japan
108.34B
9.47%
Asia
69.19B
6.05%
Latin America
58.66B
5.13%
Other
51.53B
4.50%
事業別
地域別
事業別JPY
会社名
収益
比率
Gastrointestinal diseases
344.12B
30.08%
Plasma derivatives
248.54B
21.72%
Rare diseases
190.32B
16.63%
Oncology
143.10B
12.51%
Neuroscience
141.94B
12.41%
Other
76.15B
6.66%
株主
更新時刻: Sat, May 17
更新時刻: Sat, May 17
株主統計
種類
株主統計
株主統計
比率
Capital Research Global Investors
0.42%
Parametric Portfolio Associates LLC
0.17%
Fidelity Management & Research Company LLC
0.12%
Brandes Investment Partners, L.P.
0.11%
Adage Capital Management, L.P.
0.11%
Other
99.06%
株主統計
株主統計
比率
Capital Research Global Investors
0.42%
Parametric Portfolio Associates LLC
0.17%
Fidelity Management & Research Company LLC
0.12%
Brandes Investment Partners, L.P.
0.11%
Adage Capital Management, L.P.
0.11%
Other
99.06%
種類
株主統計
比率
Investment Advisor
1.59%
Hedge Fund
0.30%
Investment Advisor/Hedge Fund
0.26%
Research Firm
0.14%
Family Office
0.01%
Family Office
0.01%
Other
97.68%
機関投資家保有株
更新時刻: Sun, Jan 19
更新時刻: Sun, Jan 19
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q1
591
73.85M
2.36%
-8.86M
2024Q4
595
73.56M
2.33%
-9.88M
2024Q3
583
77.60M
2.45%
-3.33M
2024Q2
581
73.43M
2.34%
-14.54M
2024Q1
593
78.98M
2.52%
-11.62M
2023Q4
609
83.80M
2.67%
-18.91M
2023Q3
621
81.24M
2.59%
-37.59M
2023Q2
617
84.64M
2.72%
-34.14M
2023Q1
627
84.81M
2.73%
-21.74M
2022Q4
637
69.93M
2.25%
-40.01M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Capital Research Global Investors
13.16M
0.42%
+25.31K
+0.19%
Dec 31, 2024
Parametric Portfolio Associates LLC
5.14M
0.16%
+961.51K
+23.02%
Dec 31, 2024
Fidelity Management & Research Company LLC
3.33M
0.11%
+438.69K
+15.18%
Dec 31, 2024
Brandes Investment Partners, L.P.
3.04M
0.1%
-192.02K
-5.94%
Dec 31, 2024
Renaissance Technologies LLC
3.08M
0.1%
-139.40K
-4.33%
Dec 31, 2024
Goldman Sachs Asset Management, L.P.
2.32M
0.07%
+131.24K
+6.01%
Dec 31, 2024
First Trust Advisors L.P.
3.24M
0.1%
+62.72K
+1.97%
Dec 31, 2024
Aperio Group, LLC
2.20M
0.07%
+313.03K
+16.56%
Dec 31, 2024
Van Eck Associates Corporation
2.21M
0.07%
+35.19K
+1.62%
Dec 31, 2024
詳細を見る
関連ETF
更新時刻: Fri, Jun 6
更新時刻: Fri, Jun 6
銘柄名
比率
VanEck Pharmaceutical ETF
3.89%
SGI Enhanced Global Income ETF
2.62%
Invesco Zacks Multi-Asset Income ETF
0.74%
ActivePassive International Equity ETF
0.62%
First Trust Value Line Dividend Index Fund
0.46%
Avantis Responsible International Equity ETF
0.08%
Avantis International Equity ETF
0.07%
Roundhill GLP-1 & Weight Loss ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
Pacer Global Cash Cows Dividend ETF
0%
詳細を見る
VanEck Pharmaceutical ETF
比率3.89%
SGI Enhanced Global Income ETF
比率2.62%
Invesco Zacks Multi-Asset Income ETF
比率0.74%
ActivePassive International Equity ETF
比率0.62%
First Trust Value Line Dividend Index Fund
比率0.46%
Avantis Responsible International Equity ETF
比率0.08%
Avantis International Equity ETF
比率0.07%
Roundhill GLP-1 & Weight Loss ETF
比率0%
DFA Dimensional International Core Equity 2 ETF
比率0%
Pacer Global Cash Cows Dividend ETF
比率0%
配当金
過去5年間の配当金総支払額は
1.42T
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Sep 12, 2024
TAK.NB Final Cash Dividend of gross USD 0.326079 paid on Dec 12, 2024 going ex on Sep 30, 2024
Sep 30, 2024
Dec 12, 2024
Sep 30, 2024
Mar 14, 2024
TAK.NB Interim Cash Dividend of gross USD 0.292214 paid on Jul 08, 2024 going ex on Mar 27, 2024
Mar 28, 2024
Jul 08, 2024
Mar 27, 2024
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
